Recombinant human bone morphogenetic protein 2 in augmentation procedures: case reports.
Int J Oral Maxillofac Implants
; 29(5): 1198-203, 2014.
Article
em En
| MEDLINE
| ID: mdl-25216148
ABSTRACT
To successfully rehabilitate edentulous patients using endosseous implants, there must be enough available bone. Several techniques have been proposed for augmentation of sites with insufficient bone volume. Although autogenous bone has long been considered the gold standard for such procedures, the limited availability of graft material and a high morbidity rate are potential disadvantages of this type of graft. An alternative is to use recombinant human bone morphogenetic protein 2 (rhBMP-2), which is able to support bone regeneration in the oral environment. These cases demonstrate the applicability of rhBMP-2 in maxillary sinus elevation and augmentation procedures in the maxilla to enable dental implant placement. The use of rhBMP-2 in alveolar augmentation procedures had several clinical benefits for these patients.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Fator de Crescimento Transformador beta
/
Substitutos Ósseos
/
Proteína Morfogenética Óssea 2
/
Levantamento do Assoalho do Seio Maxilar
Tipo de estudo:
Observational_studies
/
Prognostic_studies
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Int J Oral Maxillofac Implants
Assunto da revista:
ODONTOLOGIA
Ano de publicação:
2014
Tipo de documento:
Article